Barreiro EJ - Search Results

1

Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?

Thota S, Rodrigues DA, Crans DC, Barreiro EJ. Thota S, et al. Among authors: barreiro ej. J Med Chem. 2018 Jul 26;61(14):5805-5821. doi: 10.1021/acs.jmedchem.7b01689. Epub 2018 Feb 26. J Med Chem. 2018. PMID: 29446940 Review.

2

New isoxazole derivatives designed as nicotinic acetylcholine receptor ligand candidates.

Silva NM, Tributino JL, Miranda AL, Barreiro EJ, Fraga CA. Silva NM, et al. Among authors: barreiro ej. Eur J Med Chem. 2002 Feb;37(2):163-70. doi: 10.1016/s0223-5234(01)01327-7. Eur J Med Chem. 2002. PMID: 11858848

3

Novel phthalimide derivatives, designed as leukotriene D(4) receptor antagonists.

Lima LM, de Brito FC, de Souza SD, Miranda AL, Rodrigues CR, Fraga CA, Barreiro EJ. Lima LM, et al. Among authors: barreiro ej. Bioorg Med Chem Lett. 2002 Jun 3;12(11):1533-5. doi: 10.1016/s0960-894x(02)00203-2. Bioorg Med Chem Lett. 2002. PMID: 12031336

4

Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives.

Cunha AC, Figueiredo JM, Tributino JL, Miranda AL, Castro HC, Zingali RB, Fraga CA, de Souza MC, Ferreira VF, Barreiro EJ. Cunha AC, et al. Among authors: barreiro ej. Bioorg Med Chem. 2003 May 1;11(9):2051-9. doi: 10.1016/s0968-0896(03)00055-5. Bioorg Med Chem. 2003. PMID: 12670656

5

New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives.

Silva GA, Costa LM, Brito FC, Miranda AL, Barreiro EJ, Fraga CA. Silva GA, et al. Among authors: barreiro ej. Bioorg Med Chem. 2004 Jun 15;12(12):3149-58. doi: 10.1016/j.bmc.2004.04.009. Bioorg Med Chem. 2004. PMID: 15158783

6

A novel 3D-QSAR comparative molecular field analysis (CoMFA) model of imidazole and quinazolinone functionalized p38 MAP kinase inhibitors.

Sperandio da Silva GM, Sant'Anna CM, Barreiro EJ. Sperandio da Silva GM, et al. Among authors: barreiro ej. Bioorg Med Chem. 2004 Jun 15;12(12):3159-66. doi: 10.1016/j.bmc.2004.04.004. Bioorg Med Chem. 2004. PMID: 15158784

7

Bioisosterism: a useful strategy for molecular modification and drug design.

Lima LM, Barreiro EJ. Lima LM, et al. Among authors: barreiro ej. Curr Med Chem. 2005;12(1):23-49. doi: 10.2174/0929867053363540. Curr Med Chem. 2005. PMID: 15638729 Review. No abstract available.

8

Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs.

Fraga CA, Barreiro EJ. Fraga CA, et al. Among authors: barreiro ej. Curr Med Chem. 2006;13(2):167-98. doi: 10.2174/092986706775197881. Curr Med Chem. 2006. PMID: 16472212

9

Molecular docking study and development of an empirical binding free energy model for phosphodiesterase 4 inhibitors.

Oliveira FG, Sant'Anna CM, Caffarena ER, Dardenne LE, Barreiro EJ. Oliveira FG, et al. Among authors: barreiro ej. Bioorg Med Chem. 2006 Sep 1;14(17):6001-11. doi: 10.1016/j.bmc.2006.05.017. Epub 2006 Jul 14. Bioorg Med Chem. 2006. PMID: 16843671

10

Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors.

Duarte CD, Tributino JL, Lacerda DI, Martins MV, Alexandre-Moreira MS, Dutra F, Bechara EJ, De-Paula FS, Goulart MO, Ferreira J, Calixto JB, Nunes MP, Bertho AL, Miranda AL, Barreiro EJ, Fraga CA. Duarte CD, et al. Among authors: barreiro ej. Bioorg Med Chem. 2007 Mar 15;15(6):2421-33. doi: 10.1016/j.bmc.2007.01.013. Epub 2007 Jan 17. Bioorg Med Chem. 2007. PMID: 17275312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

221 results

Search Page